Showing results (1721-1730 of 5,146) with videos related to

Sort By:
Pageof 515
Multiple Sclerosis and Related Disorders|September 17, 2020
Inflammatory colitis associated with TeriflunomideNeda Zarghami Esfahani, Gloria von Geldern, Meghan C Romba, et al.
Multiple Sclerosis and Related Disorders|September 17, 2020
Off-label use of tocilizumab in neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases: A case-seriesJ Rigal, G Pugnet, J Ciron, et al.
Multiple Sclerosis and Related Disorders|September 19, 2020
Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter studyAlon Kalron, Rainer Ehling, Ilse Baert, et al.
Multiple Sclerosis and Related Disorders|August 31, 2020
Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patientsMorteza Izadi, Safa Tahmasebi, Inna Pustokhina, et al.
Multiple Sclerosis and Related Disorders|September 25, 2020
"A case report: Co-occurrence of cerebral amyloid angiopathy and multiple sclerosis"Dominik Kobylarek, Piotr Iwanowski, David Masolak, et al.
Multiple Sclerosis and Related Disorders|January 6, 2021
Differences in physical, mental, and social functions between males and females in multiple sclerosis: A multicenter cross-sectional study in ChinaZhengyang Zhao, Ying Zhang, Qin Du, et al.
Multiple Sclerosis and Related Disorders|November 29, 2020
Diffuse alveolar hemorrhage as an early complication of alemtuzumab treatment: A case report of a multiple sclerosis patient and an overview of 14 casesB R H Drop, D Zemel, B H A Wokke, et al.
Multiple Sclerosis and Related Disorders|January 11, 2021
Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: Stratification by maternal and newborn characteristics in a register-based cohort study in Finland and SwedenMarta Korjagina, Katja M Hakkarainen, Sarah Burkill, et al.
Multiple Sclerosis and Related Disorders|January 11, 2021
Factors influencing patients' willingness-to-pay for disease-modifying therapies for multiple sclerosisN Poudel, B Banjara, S Kamau, et al.
Multiple Sclerosis and Related Disorders|January 11, 2021
COVID-19 in teriflunomide-treated patients with multiple sclerosis: A case report and literature reviewFioravante Capone, Francesco Motolese, Tiziano Luce, et al.
Pageof 515